Skip to main content
OpenTrials
Completed

NCT Number: NCT02901795

Early Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes

All included patients will have their fetal heart rate recording performed with an EDAN F3 fetal monitor that allowed the back up recording of the fetal heart rate beat to beat detection. Fetal heart rate variability analysis will be performed using Matalb® software.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

CHU Rennes Hôpital Sud, Rennes, Brittany Region, France

Loading trial locations.

About this study

Preterm Premature Rupture Of Membranes (pPROM) complicates 2-3% of all pregnancies and is responsible for one-third of preterm birth. Since the membranes generally form a barrier to ascending infection, the second major complication (10-36%) of pPROM is the development of intrauterine infection, called chorioamnionitis. It involves infection/inflammation of the fetus and increases neonatal morbidity and mortality. Indeed, histological chorioamnionitis (microscopic evidence of polynuclear neutrophils on examination of the placenta), regardless the prematurity, creates an inflammatory fetal syndrome which is responsible for an increase rate of cerebral palsy, intracranial hemorrhage, sepsis, pneumonia, respiratory distress syndrome and necrotizing enterocolitis at birth.

During hospitalization, management of women who develop pPROM requires an individual assessment of the benefits and risks of continuing pregnancy versus immediate delivery to avoid chorioamnionitis. Numerous studies in recent years have failed to identify a satisfactory prenatal marker of infection to predict chorioamnionitis. It is now clearly recognized that new markers are needed to improve prediction of infection in cases of pPROM.

A retrospective study (under submission) based on 23 pregnant women with pPROM was performed in the University Hospital of Rennes between 2007 and 2012. For all the patients included, a computerized analysis of the fetal heart rate (Sonicaïd FetalCare Oxford 8002®) has been performed daily during the last six days before delivery and the last recording was made less than 24 hours before the delivery. This study found significant differences of fetal heart rate patterns from pPROM complicated by histological chorioamnionitis compared with pPROM without histological chorioamnionitis. Short term variation (p=0,003) and high variation episodes (p<0,001) decreased significantly in pPROM complicated by histological chorioamnionitis. An index based on the high variations episodes was performed and seems a promising tool for the early detection of chorioamnionitis during pPROM (sensitivity 90%, specificity 84.6%, positive predictive value 71.5%, negative predictive value 95.2%, AUC = 0.88, IC 95% 0.73 to 100).

These data are consistent with those observed in neonatology for the assessment of early-onset sepsis and the underlying pathophysiological mechanisms (decreased fetal heart rate variability and adaptability in response to the placental infection/inflammation). Therefore, fetal heart rate (FHR) characteristics could be a potential way of research still unexploited for the early detection of chorioamnionitis in cases of pPROM.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pPROM between 26 to 34 WG clinically proven or confirmed by a positive IGBP-1 protein test in a vaginal sample
  • 18 years old or older
  • singleton pregnancy

Exclusion criteria

  • multiple pregnancy
  • intra-uterine growth restriction defined by a fetal weight under the 10th percentile (AUDIPOG)
  • active smoking
  • gestational diabetes or pre-existing diabetes mellitus
  • maternal pathology :
  • congenital or acquired heart defect
  • pulmonary embolism in progress or under treatment
  • pulmonary hypertension
  • renal insufficiency
  • Chronic obstructive pulmonary disease
  • systemic lupus erythematosus, multiple sclerosis, Sjögren's syndrome
  • heart, neurological or genetic fetal proven malformations

Treatment and study plan

Primary outcomes

  1. The performance indicator

    Time frame: up to delivery

    area under ROC curve of the high variation index for the early diagnosis of histologically proven chorioamnionitis during pPROM.

  2. The performance indicator

    Time frame: up to delivery

    sensibility, specificity of the high variation index for the early diagnosis of histologically proven chorioamnionitis during pPROM.

  3. The performance indicator

    Time frame: up to delivery

    positive predictive value of the high variation index for the early diagnosis of histologically proven chorioamnionitis during pPROM.

  4. The performance indicator

    Time frame: up to delivery

    negative predictive value of the high variation index for the early diagnosis of

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Official study title

Fetal Heart Rate Variability Analysis for the Early Detection of Chorioamnionitis During Preterm Premature Rupture of Membranes

Acronym: AiRPM

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Sep 15, 2016
Registry last updated
Mar 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.